 |
Previous Article | Next Article 
The Journal of Neuroscience, November 1, 2002, 22(21):9604-9611
Differential Effects of Direct and Indirect Dopamine Agonists on
Prepulse Inhibition: A Study in D1 and D2 Receptor Knock-Out
Mice
Rebecca J.
Ralph-Williams1,
Virginia
Lehmann-Masten2,
Veronica
Otero-Corchon3,
Malcolm J.
Low3, 4, and
Mark
A.
Geyer2
1 Alcohol and Drug Abuse Research Center, Harvard
Medical School and McLean Hospital, Belmont, Massachusetts 02478, 2 Department of Psychiatry, University of California, San
Diego, La Jolla, California 92093-0804, 3 Vollum Institute
and 4 Department of Behavioral Neuroscience, Oregon Health
and Science University, Portland, Oregon 97201
Stimulation of the dopamine (DA) system disrupts prepulse
inhibition (PPI) of the acoustic startle response. On the basis of rat studies, it appeared that DA D2 receptors (D2Rs) rather than D1
receptors (D1Rs) regulate PPI, albeit possibly in synergism with D1Rs.
To characterize the DA receptor modulation of PPI in another species,
we tested DA D1R and D2R mutant mice with direct and indirect DA
agonists and with the glutamate receptor antagonist, dizocilpine
(MK-801). Neither the mixed D1/D2 agonist apomorphine (5 mg/kg) nor the
more selective D1-like agonist SKF82958 (0.3 mg/kg) altered PPI in D1R
knock-out mice, although both compounds disrupted PPI in D2R mutant and
wild-type mice, suggesting that the D1R alone might modulate PPI in
mice. However, amphetamine (10 mg/kg) significantly lowered PPI in each
genotype of D1R mice, suggesting that the D1R is not necessary for the
PPI-disruptive effect of the indirect agonist in mice. As reported
previously, amphetamine (10 mg/kg) failed to disrupt PPI in D2R
knock-out mice, supporting a unique role of the D2R in the modulation
of PPI. Dizocilpine (0.3 mg/kg) induced similar PPI deficits in D1R and
D2R mutant mice, confirming that the influences of the NMDA receptor on
PPI are independent of D1Rs and D2Rs in rodents. Thus, both D1Rs and
D2Rs modulate aspects of PPI in mice in a manner that differs from
dopaminergic modulation in rats. These findings emphasize that further
cross-species comparisons of the pharmacology of PPI are essential to
understand the relevance of rodent PPI studies to the deficits in PPI
observed in patients with schizophrenia.
Key words:
prepulse inhibition; mice; dopamine; D1 receptor; D2
receptor; knock-out; apomorphine; SKF82958; amphetamine; dizocilpine; startle response
Copyright © 2002 Society for Neuroscience 0270-6474/02/22219604-08$05.00/0
This article has been cited by other articles:

|
 |

|
 |
 
M. van den Buuse
Modeling the Positive Symptoms of Schizophrenia in Genetically Modified Mice: Pharmacology and Methodology Aspects
Schizophr Bull,
November 9, 2009;
(2009)
sbp132v1.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. P. Fadok, T. M. K. Dickerson, and R. D. Palmiter
Dopamine Is Necessary for Cue-Dependent Fear Conditioning
J. Neurosci.,
September 9, 2009;
29(36):
11089 - 11097.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Schmidt, D. S. Chapin, J. Cianfrogna, M. L. Corman, M. Hajos, J. F. Harms, W. E. Hoffman, L. A. Lebel, S. A. McCarthy, F. R. Nelson, et al.
Preclinical Characterization of Selective Phosphodiesterase 10A Inhibitors: A New Therapeutic Approach to the Treatment of Schizophrenia
J. Pharmacol. Exp. Ther.,
May 1, 2008;
325(2):
681 - 690.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. B. Caine, M. Thomsen, K. I. Gabriel, J. S. Berkowitz, L. H. Gold, G. F. Koob, S. Tonegawa, J. Zhang, and M. Xu
Lack of Self-Administration of Cocaine in Dopamine D1 Receptor Knock-Out Mice
J. Neurosci.,
November 28, 2007;
27(48):
13140 - 13150.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. L. Petryshen, A. Kirby, R. P. Hammer Jr., S. Purcell, S. B. O'Leary, J. B. Singer, A. E. Hill, J. H. Nadeau, M. J. Daly, and P. Sklar
Two Quantitative Trait Loci for Prepulse Inhibition of Startle Identified on Mouse Chromosome 16 Using Chromosome Substitution Strains
Genetics,
December 1, 2005;
171(4):
1895 - 1904.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Ralph and S. B. Caine
Dopamine D1 and D2 Agonist Effects on Prepulse Inhibition and Locomotion: Comparison of Sprague-Dawley Rats to Swiss-Webster, 129X1/SvJ, C57BL/6J, and DBA/2J Mice
J. Pharmacol. Exp. Ther.,
February 1, 2005;
312(2):
733 - 741.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Sacco, K. L. Bannon, and T. P. George
Nicotinic receptor mechanisms and cognition in normal states and neuropsychiatric disorders
J Psychopharmacol,
December 1, 2004;
18(4):
457 - 474.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Svenningsson, G. G. Nomikos, and P. Greengard
Response to Comment on "Diverse Psychotomimetics Act Through a Common Signaling Pathway"
Science,
July 9, 2004;
305(5681):
180d - 180d.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. Tsai, R. J. Ralph-Williams, M. Martina, R. Bergeron, J. Berger-Sweeney, K. S. Dunham, Z. Jiang, S. B. Caine, and J. T. Coyle
Gene knockout of glycine transporter 1: Characterization of the behavioral phenotype
PNAS,
June 1, 2004;
101(22):
8485 - 8490.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. J. Gerber and S. Tonegawa
Psychotomimetic Effects of Drugs -- A Common Pathway to Schizophrenia?
N. Engl. J. Med.,
March 4, 2004;
350(10):
1047 - 1048.
[Full Text]
[PDF]
|
 |
|
|

|